What this study is
Simplified from ClinicalTrials.govTesting ambient listening, an AI tool that records a visit and writes a summary, to learn whether it helps providers write clearer, more useful summaries of family meetings in patients 18 and older in the medical intensive care unit. Participants allow a family meeting with their ICU team to be recorded and transcribed.
Read the original summary from ClinicalTrials.gov
The goal of this clinical trial is to learn whether ambient listening can help healthcare providers create written summaries of conversations with the families of patients in the medical intensive care unit (ICU). Ambient listening is an artificial intelligence-enabled tool that records a medical visit and creates a written summary. Healthcare providers already use this technology for many types of appointments. The main questions this trial aims to answer are: Do patients, families, and healthcare providers feel comfortable using ambient listening to record and summarize ICU family meetings? and How much do healthcare providers use content created by ambient listening when it is available to them? and Can ambient listening generate useful summaries of family meetings for patients and their families? Researchers will compare clinical summaries written using an AI-enabled tool to summaries written without the tool to see if using ambient listening makes summaries clearer and more useful to healthcare providers.
Participants will:
Allow researchers to record and transcribe a family meeting with the patient's ICU medical team.
What's being tested
- Receipt of ambient listening-generated draft clinical note
Intervention · BEHAVIORAL
Intervention-arm clinicians will receive a draft structured clinical note generated by ambient listening technology immediately following the scheduled family meeting and may choose to use this draft content when creating their final signed note in the patient's medical record.
Study details
- Official title
- Pilot Trial of Ambient Listening for Intensive Care Unit Family Meeting Summaries (PALMS)
- Sponsor
- University of Pennsylvania
- Conditions
- Documentation of Serious Illness Communication for Critically Ill Patients
- Enrolling
- 30 people
- Starts
- 2026-12
- Est. completion
- 2027-06
- Design
- Single-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Be the surrogate decision maker for a patient admitted to a participating medical intensive care unit; and
- Have a family meeting scheduled with the patient's medical team.
You can't join if
- Be less than 18 years of age; or
- Be the surrogate of a patient who is less than 18 years of age; or
- Have a preferred language other than English.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openHospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Catherine Auriemma, MD, MSHP · Contact267-595-8742Catherine.Auriemma@pennmedicine.upenn.edu
Study team
Sponsor
University of Pennsylvania
Study ID 26-8441
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.